iMEAN offers systems biology-based digital organism models that improve genomic selection accuracy by up to 50% for complex crop traits like yield and pathogen resistance. Validated on Arabidopsis thaliana at TRL 6, this technology helps breeding companies accelerate R&D, reduce costs, and develop climate-resilient crop varieties.
Crop breeding programs face a critical challenge: developing varieties that are both more productive and more resilient to climate change. While genomic selection is the industry standard for optimizing breeding programs—an area with approximately $3 billion in annual R&D investment—it has limitations in predicting complex traits such as yield due to constraints in available learning datasets. iMEAN's approach addresses this gap by injecting mechanistic, systems biology information into the prediction process, enabling more accurate forecasting of crop performance.
This technology is particularly valuable for breeding companies seeking to improve prediction accuracy for traits influenced by multiple genes, epistatic interactions, and environmental variations. By combining proprietary databases, advanced algorithms, and expert curation, iMEAN reconstructs genome-scale mathematical models that simulate complex biological systems from DNA sequences and omics datasets. The result is a predictive platform that can help accelerate breeding decisions and reduce the time and cost of developing improved crop varieties.
Core approach:
Validated performance:
Target applications:
The technology has been validated at TRL 6 through a successful proof of concept on Arabidopsis thaliana, demonstrating significant improvements in prediction accuracy under both greenhouse and field conditions. The next development phase involves reconstructing digital models for crop species such as tomato, rapeseed, and sunflower, followed by demonstration on commercially relevant crops. iMEAN is actively seeking partnerships with breeding companies to validate the technology using historical breeding data and to test new predictions for traits of commercial interest. Successful demonstration on a crop species would advance the technology toward broader commercial deployment in agricultural breeding programs.
iMEAN is a deeptech company specializing in computational modeling and predictive biology. The company reconstructs digital organisms—mathematical representations of molecular networks at the genome scale—to simulate complex biological systems. Using an in-house platform that combines proprietary databases, algorithms, and expert curation, iMEAN generates high-quality predictive models from DNA sequences and omics datasets. These tools help researchers and biotechnology companies extract actionable biological insights, identify metabolic targets, and optimize bioprocesses across agriculture, food, environmental, and health sectors.
By providing these in silico services, iMEAN enables customers to accelerate R&D and improve the efficiency of their biological projects. The company has supported industrial and academic partners by resolving bottlenecks and delivering models that have reached industrial scale. Notable collaborations include work in sustainable crop protection and participation in the Ferments du Futur consortium to drive innovation in fermented foods and biopreservation. With a team of scientists focused on systems biology and biostatistics, iMEAN supports the transition toward more sustainable industrial practices through data-driven prediction and analysis.